866-997-4948(US-Canada Toll Free)

United States Prophylactic Human Vaccine Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 113 Pages

Notes:
Sales, means the sales volume of Prophylactic Human Vaccine
Revenue, means the sales value of Prophylactic Human Vaccine

This report studies sales (consumption) of Prophylactic Human Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Bavarian Nordic A/S
BiondVax Pharmaceuticals Ltd
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer
Sanofi Pasteur SA
Serum Institute of India Pvt
Shanghai BravoBio

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Prophylactic Human Vaccine in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Prophylactic Human Vaccine Market Report 2017
1 Prophylactic Human Vaccine Overview
1.1 Product Overview and Scope of Prophylactic Human Vaccine
1.2 Classification of Prophylactic Human Vaccine
1.2.1 Type I
1.2.2 Type II
1.3 Application of Prophylactic Human Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Prophylactic Human Vaccine (2012-2022)
1.4.1 United States Prophylactic Human Vaccine Sales and Growth Rate (2012-2022)
1.4.2 United States Prophylactic Human Vaccine Revenue and Growth Rate (2012-2022)

2 United States Prophylactic Human Vaccine Competition by Manufacturers
2.1 United States Prophylactic Human Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Prophylactic Human Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Prophylactic Human Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Prophylactic Human Vaccine Market Competitive Situation and Trends
2.4.1 Prophylactic Human Vaccine Market Concentration Rate
2.4.2 Prophylactic Human Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Prophylactic Human Vaccine Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Prophylactic Human Vaccine Sales and Market Share by States (2012-2017)
3.2 United States Prophylactic Human Vaccine Revenue and Market Share by States (2012-2017)
3.3 United States Prophylactic Human Vaccine Price by States (2012-2017)

4 United States Prophylactic Human Vaccine Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Prophylactic Human Vaccine Sales and Market Share by Type (2012-2017)
4.2 United States Prophylactic Human Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Prophylactic Human Vaccine Price by Type (2012-2017)
4.4 United States Prophylactic Human Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Prophylactic Human Vaccine Sales (Volume) by Application (2012-2017)
5.1 United States Prophylactic Human Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Prophylactic Human Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Prophylactic Human Vaccine Manufacturers Profiles/Analysis
6.1 Bavarian Nordic A/S
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Prophylactic Human Vaccine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bavarian Nordic A/S Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 BiondVax Pharmaceuticals Ltd
6.2.2 Prophylactic Human Vaccine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Bharat Biotech International Limited
6.3.2 Prophylactic Human Vaccine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Bharat Biotech International Limited Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Prophylactic Human Vaccine Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Hualan Biological Engineering
6.5.2 Prophylactic Human Vaccine Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Hualan Biological Engineering Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Janssen Pharmaceuticals
6.6.2 Prophylactic Human Vaccine Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Janssen Pharmaceuticals Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 MedImmune
6.7.2 Prophylactic Human Vaccine Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 MedImmune Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Merck
6.8.2 Prophylactic Human Vaccine Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Merck Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Pfizer
6.9.2 Prophylactic Human Vaccine Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Pfizer Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Sanofi Pasteur SA
6.10.2 Prophylactic Human Vaccine Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Sanofi Pasteur SA Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Serum Institute of India Pvt
6.12 Shanghai BravoBio

7 Prophylactic Human Vaccine Manufacturing Cost Analysis
7.1 Prophylactic Human Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prophylactic Human Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Prophylactic Human Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Prophylactic Human Vaccine Market Forecast (2017-2022)
11.1 United States Prophylactic Human Vaccine Sales, Revenue Forecast (2017-2022)
11.2 United States Prophylactic Human Vaccine Sales Forecast by Type (2017-2022)
11.3 United States Prophylactic Human Vaccine Sales Forecast by Application (2017-2022)
11.4 Prophylactic Human Vaccine Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Prophylactic Human Vaccine
Table Classification of Prophylactic Human Vaccine
Figure United States Sales Market Share of Prophylactic Human Vaccine by Type in 2015
Table Application of Prophylactic Human Vaccine
Figure United States Sales Market Share of Prophylactic Human Vaccine by Application in 2015
Figure United States Prophylactic Human Vaccine Sales and Growth Rate (2012-2022)
Figure United States Prophylactic Human Vaccine Revenue and Growth Rate (2012-2022)
Table United States Prophylactic Human Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Prophylactic Human Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prophylactic Human Vaccine Sales Share by Manufacturers
Figure 2016 Prophylactic Human Vaccine Sales Share by Manufacturers
Table United States Prophylactic Human Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Prophylactic Human Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Prophylactic Human Vaccine Revenue Share by Manufacturers
Table 2016 United States Prophylactic Human Vaccine Revenue Share by Manufacturers
Table United States Market Prophylactic Human Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Prophylactic Human Vaccine Average Price of Key Manufacturers in 2015
Figure Prophylactic Human Vaccine Market Share of Top 3 Manufacturers
Figure Prophylactic Human Vaccine Market Share of Top 5 Manufacturers
Table United States Prophylactic Human Vaccine Sales by States (2012-2017)
Table United States Prophylactic Human Vaccine Sales Share by States (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Market Share by States in 2015
Table United States Prophylactic Human Vaccine Revenue and Market Share by States (2012-2017)
Table United States Prophylactic Human Vaccine Revenue Share by States (2012-2017)
Figure Revenue Market Share of Prophylactic Human Vaccine by States (2012-2017)
Table United States Prophylactic Human Vaccine Price by States (2012-2017)
Table United States Prophylactic Human Vaccine Sales by Type (2012-2017)
Table United States Prophylactic Human Vaccine Sales Share by Type (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Market Share by Type in 2015
Table United States Prophylactic Human Vaccine Revenue and Market Share by Type (2012-2017)
Table United States Prophylactic Human Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prophylactic Human Vaccine by Type (2012-2017)
Table United States Prophylactic Human Vaccine Price by Type (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Prophylactic Human Vaccine Sales by Application (2012-2017)
Table United States Prophylactic Human Vaccine Sales Market Share by Application (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Market Share by Application in 2015
Table United States Prophylactic Human Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Growth Rate by Application (2012-2017)
Table Bavarian Nordic A/S Basic Information List
Table Bavarian Nordic A/S Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bavarian Nordic A/S Prophylactic Human Vaccine Sales Market Share (2012-2017)
Table BiondVax Pharmaceuticals Ltd Basic Information List
Table BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Sales Market Share (2012-2017)
Table Bharat Biotech International Limited Basic Information List
Table Bharat Biotech International Limited Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bharat Biotech International Limited Prophylactic Human Vaccine Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Prophylactic Human Vaccine Sales Market Share (2012-2017)
Table Hualan Biological Engineering Basic Information List
Table Hualan Biological Engineering Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hualan Biological Engineering Prophylactic Human Vaccine Sales Market Share (2012-2017)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceuticals Prophylactic Human Vaccine Sales Market Share (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune Prophylactic Human Vaccine Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Prophylactic Human Vaccine Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Prophylactic Human Vaccine Sales Market Share (2012-2017)
Table Sanofi Pasteur SA Basic Information List
Table Sanofi Pasteur SA Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Pasteur SA Prophylactic Human Vaccine Sales Market Share (2012-2017)
Table Serum Institute of India Pvt Basic Information List
Table Shanghai BravoBio Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Human Vaccine
Figure Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure Prophylactic Human Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
Table Major Buyers of Prophylactic Human Vaccine
Table Distributors/Traders List
Figure United States Prophylactic Human Vaccine Production and Growth Rate Forecast (2017-2022)
Figure United States Prophylactic Human Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table United States Prophylactic Human Vaccine Production Forecast by Type (2017-2022)
Table United States Prophylactic Human Vaccine Consumption Forecast by Application (2017-2022)
Table United States Prophylactic Human Vaccine Sales Forecast by States (2017-2022)
Table United States Prophylactic Human Vaccine Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *